BRONX, N.Y., Sept. 22, 2015 /PRNewswire/ -- Pure genius is not something that is witnessed on a daily basis. It is even less common to find someone who truly utilizes both hemispheres of the brain, especially in the scientific community. Yet this is certainly the case with Dr. Patricia Ann Broderick, who has earned recognition as a Pinnacle Awardee by Continental Who's Who.
While a lot of scientists can be strictly analytical by nature, Dr. Broderick throws caution to the wind, which has led to her becoming a true pioneer in the medical industry. Her extraordinary knowledge and tremendous foresight has allowed for her to lead a career filled with countless accomplishments.
Among her long list of professional achievements, Dr. Broderick is the inventor of the trademarked and patented BRODERICK PROBE® biosensors and related biotechnologies. The BRODERICK PROBE® is a diagnostic biomedical device that sends neurotransmitter images in real time from the brain during live movement and so video tracks the brain for personalized medicine. This brilliant invention, named for her father, has become a popular tool in the study of treatments for neurodegenerative diseases and drug addiction.
As a result of her innumerable hours of research and her true dedication to the well-being of both patients in the clinical setting and other mammalian brains, Dr. Broderick has invented, developed, patented, and trademarked this series of biosensors as well as the electrical circuits which direct the sensing work of the biosensor for this Neuromolecular Imaging (NMI) technique. She also established the Broderick Brain Foundation in order to fund training for healthcare and educational professionals as well as students in their quest to discover how the brain truly works.
Highly sought after due to her significant skills and expertise, Dr. Broderick currently fills several key roles in the medical field. She serves as a Medical Professor in Physiology, Pharmacology and Neuroscience as well as the Course Director in Pharmacology for the Physician Assistant Program at the City University of New York School of Medicine, Sophie Davis School of Biomedical Education at City College. Dr. Broderick also works as part of the Doctoral Faculty in Biology (Neuroscience) at the CUNY Graduate School. In addition, she is an Adjunct Professor in Neurology at the NYU Langone Medical Center and Comprehensive Epilepsy Center.
An extensively educated individual, Dr. Broderick earned a Bachelor of Science degree from St. Thomas Aquinas College (Magna cum Laude), Master of Science degree in Biology from Fordham University and a PhD in Pharmacology from St. John's University, where she was a member of the Rho Chi National Pharmaceutical Honor Society. She also performed postdoctoral and research associate work at the Albert Einstein College of Medicine and Cornell University Medical School.
Further evidencing her remarkable reputation that she has earned in her field, Dr. Broderick is a member of the American Society for Pharmacology and Experimental Therapeutics, Society for Neuroscience, Association for Women in Science, Electrochemical Society and the American Epilepsy Society. In addition, she has been the recipient of various awards, including an Outstanding Woman Scientist Award from the New York Academy of Sciences and the Milton Rosenbaum Award from the Albert Einstein College of Medicine/Montefiore Medical Center as well as being recognized as a 2014 National Association of Professional Women (NAPW) Professional Woman of the Year, 2014 Industry Expert Award from the National Association of Distinguished Professors (NADP), 2015 Faculty Row Award, and she will be featured in the forthcoming Women of Distinction Magazine, Spring Issue, 2016.
Dr. Broderick is in the process of finishing her book, Neuroimaging, Sensing Biochemistry in the Brain, for publication by Pan Stanford Publishing Inc. in Singapore. She also currently continues her work in the universities, serves as a keynote speaker at cutting edge conferences, and holds editorial appointments worldwide. In addition, Professor Broderick is the founder of a new nanotech company, known as Eazysense Nanotechnologies Inc. The new company is incorporated in New York, with co-founder in Canada, Stephen Jones, Ph.D., EMBA. It is a North American company that was established to make this unique brain nanobiosensor available and affordable for healthcare professionals and students on a global scale.
Already having put together an extraordinary career, filled with numerous significant accomplishments, Dr. Broderick continues to forge ahead, pouring every ounce of her being towards the greater good. Despite the fact that she has established herself as an icon in her industry, her work is far from complete. Never resting on her laurels, Dr. Broderick remains steadfast in her pursuit of perfection, seeking to improve the lives of others every step of the way.
The National Institutes of Health: "The NMI technique is very innovative and has many advantages over other methods of real time neurochemical sampling."
Dr. Edwin Kolodny, MD, formerly of NYU Langone Medical Center: "These are real time measurements over long periods of time in a living brain; the implications are awesome."
Dr. Steven V. Pacia, MD, NYU Langone and Director, Lenox Hill Epilepsy Division: "This unique biosensor represents a significant shift in the way that physicians and scientists study the chemistry of the brain."
Contact: Robert Basilin, 516-825-5634, email@example.com
SOURCE Continental Who's Who